University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

Simple item page
dc.contributor.authorRECOVERY Collaborative Group
dc.contributor.authorCooper, Jamie
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2025-10-15T14:03:01Z
dc.date.issued2023-12
dc.descriptionAbove all, we would like to thank the thousands of patients who participated in this trial. We would also like to thank the many doctors, nurses, pharmacists, other allied health professionals, and research administrators at NHS hospital organisations across the whole of the UK, supported by staff at the National Institute of Health Research (NIHR) Clinical Research Network, NHS DigiTrials, Public Health England, Department of Health and Social Care, the Intensive Care National Audit and Research Centre, Public Health Scotland, National Records Service of Scotland, the Secure Anonymised Information Linkage at University of Swansea, and the NHS in England, Scotland, Wales, and Northern Ireland.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent798758
dc.identifier306076783
dc.identifiere359e8f8-c323-4a97-ba90-118845a7787b
dc.identifier37865101
dc.identifier85176327080
dc.identifier.citationRECOVERY Collaborative Group & Cooper, J 2023, 'Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial', The lancet. Diabetes & endocrinology, vol. 11, no. 12, pp. 905-914. https://doi.org/10.1016/S2213-8587(23)00253-Xen
dc.identifier.doi10.1016/S2213-8587(23)00253-X
dc.identifier.issn2213-8587
dc.identifier.otherPubMedCentral: PMC10957483
dc.identifier.otherORCID: /0000-0003-3812-7026/work/194700171
dc.identifier.urihttps://hdl.handle.net/2164/26231
dc.language.isoeng
dc.relation.ispartofThe lancet. Diabetes & endocrinologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAdulten
dc.subjectHumansen
dc.subjectCOVID-19en
dc.subjectSARS-CoV-2en
dc.subjectHospitalizationen
dc.subjectHospitalsen
dc.subjectTreatment Outcomeen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subjectDASen
dc.subjectLinken
dc.subject.lccR1en
dc.titleEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Recovery_TLDE_Empagliflozin_in_Patients_VOR.pdf
Size:
780.04 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress